Hegseth Proposes Testosterone Therapy for Troops

The U.S. Department of Defense has announced plans to offer testosterone therapy to active‑duty personnel as part of a broader initiative to address hormone-related health issues. The proposal, introduced by Secretary of Defense Lloyd Austin, cites rising reports of low testosterone levels among service members and aims to improve physical performance, morale, and overall readiness.

Medical experts caution that testosterone regulation is highly individualized, with significant risks of side effects such as cardiovascular complications, infertility, and mood disturbances. Critics argue that the program lacks a robust framework for screening, monitoring, and managing long‑term health outcomes. The Department of Defense has not yet released detailed guidelines or clinical protocols, and several professional associations have called for a more evidence‑based approach before widespread implementation.

Until comprehensive studies and clear safety protocols are established, the initiative remains controversial. The Defense Department will reportedly conduct a pilot program and gather data to assess efficacy and safety, but stakeholders emphasize the need for rigorous oversight to avoid unintended health consequences for service members.